Bayer opens $44M expansion, Meribel Pharma launches, Ginkgo gets $29M contract, plus partnerships for Chime, Atelerix, ...

UnitedHealth Group reported disappointing first-quarter earnings and cut its financial guidance, hit by high costs in its ...

Eli Lilly reported the first Phase 3 data for its oral GLP-1 orforglipron Thursday morning, saying the drug succeeded in a ...

The Dutch government is committing €1.3 billion ($1.5 billion) to support biotech as part of a broader raft of measures ...

Jacob Elkins has left Sarepta to take the CMO job at AIRNA, the RNA editing shop that disclosed a $155 million Series ...

A CDC advisory panel voted to recommend RSV vaccines for at-risk adults 50 to 59, a sought-after expansion by vaccine makers ...

The London biotech Charm Therapeutics is looking for a new top executive to replace founding CEO Laksh Aithani, Endpoints ...

Trump's drug pricing EO includes wins on pill penalty reform, faster approvals, and PBM rules, but adds scrutiny on pricing ...

Trump's pharma tariffs prompt companies to assess vulnerabilities. J&J expects $400M in costs. Immunocore's Kimmtrak, ...

Port Therapeutics and other early biotech startups face funding challenges as investors prefer clinical-stage companies, with ...

A rival bid by Ayrmid for bluebird bio hasn't crossed the finish line, the biotech said, after failing to confirm financing ...

Trump signs EO on drug pricing, supports PhRMA reforms for Medicare negotiations timeline, calls for Canadian drug imports, ...